Alzheimer's disease (AD) is the most common cause of dementia among the elderly,
affecting 5% of Americans over age 65, and 20% over age 80. An excess of senile plaques …

Alzheimer's disease (AD) is one of the main causes of disability and dependency among
elderly people. AD is a neurodegenerative disorder characterized by a progressive and …

Approximately 35 million people worldwide suffer from Alzheimer's disease (AD). The
cellular uptake and specific transport of drugs and imaging agents to brain are common …

Alzheimer's disease (AD) is the most common cause of memory disruption in elderly
subjects, with the prevalence continuing to rise mainly because of the aging world …

Alzheimer's disease (AD) is a progressive and fatal neurodegenerative condition and the
most prevalent cause of dementia. This disease is characterized by progressive cognitive …

Alzheimer's disease (AD) is the most common neurodegenerative disorder that leads to
cognitive and behavioral impairment. Unfortunately, both effective diagnosis and treatment …

The present review deals in-depth with the current application of nanotechnology in
targeting the major pathological hallmarks of Alzheimer's disease. This review further …

Alzheimer's disease (AD) is a multifactorial neurodegenerative disease clinically
characterized by progressive loss of memory, impairment cognitive function, and …

This study aims to prepare, characterize and evaluate the pharmacokinetics of liposomal
donepezil HCl (LDH) dispersed into thiolated chitosan hydrogel (TCH) in rabbits. Various …

Alzheimer's disease (AD) is a progressive neurological disorder and is the most common
type of dementia. Amyloid β (Aβ) plaques play an important role in the pathophysiology of …